info@traineya.com +1-661-336-9555

Impact Assessments For Supplier Change Notices

instructor
By: Alan M Golden
Recorded Session
Duration
60 Minutes
Training Level
Intermediate to Advanced

Email Reminder

Transcript

Recorded Session

USB

For multiple location please contact our customer care team
Contact: +1-661-336-9555.



$

Webinar Details

This webinar will present strategies and tools for doing a complete and comprehensive impact assessment of supplier change notices. Tools and procedures for deciding if full impact assessments need to be processed and when notices for lower impact changes can be accepted or rejected without a full assessment will be discussed. Who (what skill sets) should be on the impact assessment team, how often to meet and methods for evaluating change notices will also be discussed. Supplier agreements and quality agreements with suppliers and vendors as well as using risk based approaches to impact assessments will be highlighted.

WHY SHOULD YOU ATTEND?

Any manufacturer of pharmaceutical products or medical devices will have vendors and suppliers in order to acquire the materials needed for manufacturing product. In a regulated environment, the manufacturer is responsible for the quality and source of all incoming materials. When supplier or vendors make changes to material, its own manufacturing or supplier they should tell the manufacturer about these changes via a supplier change notice. Without proper evaluation of the change, unforeseen changes could occur in the product leading to failed manufacturing runs or the release of non-conforming material to market. Regulatory agencies (FDA) expect manufactures to be in control of all incoming material, therefore failure to do a proper impact assessment of supplier changes could also lead to enforcement action and/or product recall. Manufactures need a robust process ensure all vendors and suppliers provide change notices and to evaluate all notices for impact. 

AREA COVERED

  • Introduction to supplier change notices
  • Regulatory impact of supplier change notices
  • Risk based approach to categorizing supplier change notices
  • Key skill sets needed to evaluate supplier change notices
  • Verification and Validation of supplier change notices
  • Key tools to help in impact assessments of supplier change notices 

LEARNING OBJECTIVES

  • Understanding supplier change notices
  • Categorization of change notices based on risk
  • Setting up a change impact team
  • Supplier/vendor quality agreements and supplier agreements
  • What happens if the change is unacceptable
  • How to set up incoming material specifications
     

WHO WILL BENEFIT?

  • QA professionals
  • Technical scientists
  • Production staff
  • Regulatory Affairs professionals
  • Supply chain professionals

Any manufacturer of pharmaceutical products or medical devices will have vendors and suppliers in order to acquire the materials needed for manufacturing product. In a regulated environment, the manufacturer is responsible for the quality and source of all incoming materials. When supplier or vendors make changes to material, its own manufacturing or supplier they should tell the manufacturer about these changes via a supplier change notice. Without proper evaluation of the change, unforeseen changes could occur in the product leading to failed manufacturing runs or the release of non-conforming material to market. Regulatory agencies (FDA) expect manufactures to be in control of all incoming material, therefore failure to do a proper impact assessment of supplier changes could also lead to enforcement action and/or product recall. Manufactures need a robust process ensure all vendors and suppliers provide change notices and to evaluate all notices for impact. 

  • Introduction to supplier change notices
  • Regulatory impact of supplier change notices
  • Risk based approach to categorizing supplier change notices
  • Key skill sets needed to evaluate supplier change notices
  • Verification and Validation of supplier change notices
  • Key tools to help in impact assessments of supplier change notices 
  • Understanding supplier change notices
  • Categorization of change notices based on risk
  • Setting up a change impact team
  • Supplier/vendor quality agreements and supplier agreements
  • What happens if the change is unacceptable
  • How to set up incoming material specifications
     
  • QA professionals
  • Technical scientists
  • Production staff
  • Regulatory Affairs professionals
  • Supply chain professionals

SPEAKER PROFILE

instructor

Alan M Golden has over 30 years of experience in the medical device industry, both in basic research and quality assurance. Alan spent 31 years at Abbott Laboratories. For the first 16 years as part of diagnostics R&D, he developed recombinant proteins used in diagnostics tests, received three US patents, and published numerous papers and abstracts. Alan then transitioned to a quality assurance role wherein both the Abbott Diagnostics and Abbott Molecular divisions, he was responsible for quality assurance for new product development, on-market product support, and operations.

Alan’s quality assurance experience extends from design control, change control, risk management, CAPA, process and test method validation, and statistics. He has been lecturing on these topics worldwide for over 10 years.

Alan retired from Abbott in 2018 and now runs Design Quality Consultants, providing training, workshops, and seminars in many areas of quality assurance.

Alan received his BS degree in Microbiology from the University of Michigan and his MS degree in Molecular Biology and Immunochemistry from the University of Illinois.

Upcoming Webinars